Idiopathic vocal cord paralysis
ICD-10 J38.0 · ICD-11 CA0H.0.1

Idiopathic Vocal Cord Paralysis with Aspiration When Spontaneous Recovery Is Expected

In some patients with idiopathic vocal cord paralysis, spontaneous recovery remains possible — yet the clinical picture cannot wait. When aspiration or an uncompensated voice is present, earlier active management is warranted even while recovery is still anticipated.

Clinical Scenario

Prognosis is transient or uncertain. Despite the expectation of spontaneous recovery of vocal fold mobility, the patient presents with aspiration and/or an uncompensated voice — findings that require prompt, targeted intervention to prevent complications and preserve quality of life during the recovery period.

Treatment Approach

Partial overview — full regimen available via the button below

Early, active intervention using a temporary injectable approach is the preferred strategy in this setting. The complete selection criteria, clinical decision points, and alternative options are detailed in the full protocol.

Treatment Goal

Recovery of vocal fold mobility within 6–12 months from onset.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1177/0194599817751030

IL can be applied at any stage of UVFP. Early and active intervention with temporary injection materials is recommended to prevent lung complications and to ensure the quality of life of a patient with high vocal demands (strong recommendation, moderate-quality evidence).

Temporary or short-duration materials are used when spontaneous recovery of vocal fold mobility is expected (strong recommendation, moderate-quality evidence).

For patients with a compensated voice and no aspiration, less invasive treatment, such as a wait-and-see approach, IL with temporary material, and voice therapy are applicable, depending on the patient's need or profession, but for patients with a high vocal demand, uncompensated voice, or aspiration/dysphagia, SMPs are preferred.

Spontaneous recovery of vocal fold mobility can occur within 6–12 months from the onset of UVFP (strong recommendation, moderate-quality evidence).

View source ↗